CGTX Annual EBIT
-$25.76 M
-$4.39 M-20.55%
31 December 2023
Summary:
As of January 21, 2025, CGTX annual earnings before interest & taxes is -$25.76 million, with the most recent change of -$4.39 million (-20.55%) on December 31, 2023. During the last 3 years, it has fallen by -$19.67 million (-323.14%). CGTX annual EBIT is now -574.72% below its all-time high of -$3.74 million.CGTX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CGTX Quarterly EBIT
-$9.93 M
-$2.90 M-41.23%
30 September 2024
Summary:
As of January 21, 2025, CGTX quarterly earnings before interest & taxes is -$9.93 million, with the most recent change of -$2.90 million (-41.23%) on September 30, 2024. Over the past year, it has dropped by -$3.19 million (-47.24%). CGTX quarterly EBIT is now -1407.11% below its all-time high of $760.00 thousand, reached on March 31, 2021.CGTX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CGTX TTM EBIT
-$34.24 M
-$3.19 M-10.26%
30 September 2024
Summary:
As of January 21, 2025, CGTX TTM earnings before interest & taxes is -$34.24 million, with the most recent change of -$3.19 million (-10.26%) on September 30, 2024. Over the past year, it has dropped by -$11.44 million (-50.17%). CGTX TTM EBIT is now -1435.47% below its all-time high of -$2.23 million, reached on March 31, 2020.CGTX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CGTX EBIT Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -20.6% | -47.2% | -50.2% |
3 y3 years | -323.1% | -47.2% | -50.2% |
5 y5 years | -574.7% | -47.2% | -50.2% |
CGTX EBIT High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -138.0% | at low | -168.2% | at low | -216.4% | at low |
5 y | 5-year | -574.7% | at low | -1407.1% | at low | -1435.5% | at low |
alltime | all time | -574.7% | at low | -1407.1% | at low | -1435.5% | at low |
Cognition Therapeutics EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$9.93 M(+41.2%) | -$34.24 M(+10.3%) |
June 2024 | - | -$7.03 M(-23.0%) | -$31.05 M(+8.1%) |
Mar 2024 | - | -$9.14 M(+12.4%) | -$28.74 M(+11.6%) |
Dec 2023 | -$25.76 M(+20.6%) | -$8.13 M(+20.5%) | -$25.76 M(+13.0%) |
Sept 2023 | - | -$6.75 M(+42.9%) | -$22.80 M(+0.5%) |
June 2023 | - | -$4.72 M(-23.4%) | -$22.68 M(-4.8%) |
Mar 2023 | - | -$6.16 M(+19.1%) | -$23.83 M(+11.5%) |
Dec 2022 | -$21.37 M | -$5.17 M(-21.9%) | -$21.37 M(-9.2%) |
Sept 2022 | - | -$6.62 M(+12.8%) | -$23.54 M(+17.5%) |
June 2022 | - | -$5.87 M(+58.5%) | -$20.02 M(+31.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | -$3.70 M(-49.5%) | -$15.29 M(+41.2%) |
Dec 2021 | -$10.82 M(+77.8%) | -$7.34 M(+136.0%) | -$10.82 M(+124.5%) |
Sept 2021 | - | -$3.11 M(+174.5%) | -$4.82 M(+60.9%) |
June 2021 | - | -$1.13 M(-249.1%) | -$3.00 M(-3.3%) |
Mar 2021 | - | $760.00 K(-156.8%) | -$3.10 M(-49.1%) |
Dec 2020 | -$6.09 M(+59.5%) | -$1.34 M(+4.2%) | -$6.09 M(+28.2%) |
Sept 2020 | - | -$1.28 M(+4.1%) | -$4.75 M(+37.1%) |
June 2020 | - | -$1.23 M(-44.7%) | -$3.46 M(+55.3%) |
Mar 2020 | - | -$2.23 M | -$2.23 M |
Dec 2019 | -$3.82 M | - | - |
FAQ
- What is Cognition Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Cognition Therapeutics?
- What is Cognition Therapeutics annual EBIT year-on-year change?
- What is Cognition Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Cognition Therapeutics?
- What is Cognition Therapeutics quarterly EBIT year-on-year change?
- What is Cognition Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Cognition Therapeutics?
- What is Cognition Therapeutics TTM EBIT year-on-year change?
What is Cognition Therapeutics annual earnings before interest & taxes?
The current annual EBIT of CGTX is -$25.76 M
What is the all time high annual EBIT for Cognition Therapeutics?
Cognition Therapeutics all-time high annual earnings before interest & taxes is -$3.74 M
What is Cognition Therapeutics annual EBIT year-on-year change?
Over the past year, CGTX annual earnings before interest & taxes has changed by -$4.39 M (-20.55%)
What is Cognition Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of CGTX is -$9.93 M
What is the all time high quarterly EBIT for Cognition Therapeutics?
Cognition Therapeutics all-time high quarterly earnings before interest & taxes is $760.00 K
What is Cognition Therapeutics quarterly EBIT year-on-year change?
Over the past year, CGTX quarterly earnings before interest & taxes has changed by -$3.19 M (-47.24%)
What is Cognition Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of CGTX is -$34.24 M
What is the all time high TTM EBIT for Cognition Therapeutics?
Cognition Therapeutics all-time high TTM earnings before interest & taxes is -$2.23 M
What is Cognition Therapeutics TTM EBIT year-on-year change?
Over the past year, CGTX TTM earnings before interest & taxes has changed by -$11.44 M (-50.17%)